SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium
Sep.3 (WED) | Date | Sep.4 (THU) | ||||
---|---|---|---|---|---|---|
Room D (Walker Hall 2) |
Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
08:40-10:10 | JS 01 ASCO/KSMO |
JS 02 KCSG/KSMO |
ES 02 | SS 01 | SL 01 (8:40-9:20) ![]() |
|
SL 02 (9:30-10:10) ![]() |
||||||
10:10-10:20 | Break (10 min.) | |||||
10:20-10:40 | Opening Ceremony (10:20-10:40) |
|||||
10:40-11:20 | PL 01 | |||||
11:20-11:30 | Break (10 min.) | |||||
11:30-12:10 | LS 01![]() |
LS 02![]() |
LS 03![]() |
LS 04![]() |
LS 05![]() |
|
12:10-12:20 | Break (10 min.) | |||||
12:20-13:50 | SS 02 | ES 03 | SS 03 | JS 03 KOSRO/KSMO |
SL 03 (12:20-13:00) ![]() |
|
SL 04 (13:10-13:50) ![]() |
||||||
13:50-14:00 | Break (10 min.) | |||||
KSMO Initiatives for Cancer Care Inequity (14:00-16:00) |
14:00-15:30 | JS 04 ESMO/KSMO |
JS 05 KSSO/KSMO |
ES 04 | SS 04 | SL 05 (14:00-14:40) ![]() |
SL 06 (14:50-15:30) ![]() |
||||||
15:30-15:40 | Break (10 min.) | |||||
15:40-16:20 | PL 02 | |||||
Break (10 min.) | ||||||
ES 01 (16:10-17:30) |
||||||
16:20-17:50 | SS 05 | OP 01 16:20-17:20 |
SS 06 | JS 06 KSR/KSMO |
SL 07 (16:20-17:00) ![]() |
|
Break (10 min.) | ||||||
Welcome Reception (17:40~) |
SL 08 (17:10-17:50) ![]() |
Date | Sep.5 (FRI) | ||||
---|---|---|---|---|---|
Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
08:40-10:10 | JS 07 JSMO/KSMO |
ES 05 | SS 07 | JS 08 KSP/KSMO |
SL 09 (8:40-9:20) ![]() |
SL 10 (9:30-10:10) ![]() |
|||||
10:10-10:30 | Break (20 min.) | ||||
10:30-11:10 | PL 03 | ||||
11:10-11:30 | Break (20 min.) | ||||
11:30-12:10 | LS 06![]() |
LS 07![]() |
LS 08![]() |
LS 09![]() |
LS 10![]() |
12:10-12:20 | Break (10 min.) | ||||
12:20-13:50 | JS 09 ASCO/KSMO |
OP 02 12:20-13:20 |
MDCD | SS 08 | SL 11 (12:20-13:00) ![]() |
SL 12 (13:10-13:50) ![]() |
|||||
13:50-14:00 | Break (10 min.) | ||||
14:00-14:40 | PL 04 | |
||||
14:40-14:50 | Break (10 min.) | ||||
14:50-16:20 | JS 10 ESMO/KSMO |
SS 09 | SS 10 | SL 13 (14:50-15:30) ![]() |
|
SL 14 (15:40-16:20) ![]() |
|||||
16:20-16:40 | Closing Ceremony | ||||
Date | Sep.3 (WED) |
---|---|
Time | Room D (Walker Hall 2) |
14:00-16:00 | KSMO Initiatives for Cancer Care Inequity |
16:00-16:10 | Break (10 min.) |
16:10-17:30 | ES 01 Symptom management in advanced cancer: Innovations and best practices |
17:30-17:40 | Break (10 min.) |
17:40~ | Welcome Reception |
Date | Sep.4 (THU) | ||||
---|---|---|---|---|---|
Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
08:40-10:10 | JS 01 ASCO/KSMO |
JS 02 KCSG/KSMO Transforming Oncology Research: AI-Powered Clinical Trials |
ES 02 Tumor heterogeneity and single-cell analysis KOR |
SS 01 Optimizing the transition to palliative care: Prognostic estimation and communication in oncology |
SL 01 (8:40-9:20) ![]() |
SL 02 (9:30-10:10) ![]() |
|||||
10:10-10:20 | Break (10 min.) | ||||
10:20-10:40 | Opening Ceremony (10:20-10:40) |
||||
10:40-11:20 | PL 01 Breaking new ground: Innovative cancer vaccine therapies |
||||
11:20-11:30 | Break (10 min.) | ||||
11:30-12:10 | LS 01![]() |
LS 02![]() |
LS 03![]() |
LS 04![]() |
LS 05![]() |
12:10-12:20 | Break (10 min.) | ||||
12:20-13:50 | SS 02 Revolutionizing GI cancer care with next-generation modalities |
ES 03 Cancer survivorship: Shifting paradigms in care KOR |
SS 03 How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead |
JS 03 KOSRO/KSMO Optimization of neoadjuvant/adjuvant treatment |
SL 03 (12:20-13:00) ![]() |
SL 04 (13:10-13:50) ![]() |
|||||
13:50-14:00 | Break (10 min.) | ||||
14:00-15:30 | JS 04 ESMO/KSMO ESMO guideline and the implementation in Asian Pacific Region |
JS 05 KSSO/KSMO Omit surgery in GI cancer treatment |
ES 04 Toxicity management in Antibody-Drug Conjugates (ADCs) KOR |
SS 04 Current trends and future perspectives in GU oncology |
SL 05 (14:00-14:40) ![]() |
SL 06 (14:50-15:30) ![]() |
|||||
15:30-15:40 | Break (10 min.) | ||||
15:40-16:20 | PL 02 Cancer cachexia: Transition from science to practice |
||||
16:20-17:50 | SS 05 Current insights and future directions of MBC treatment |
OP 01 16:20-17:20 |
SS 06 Clinical promise of ctDNA-based MRD testing in solid tumors |
JS 06 KSR/KSMO Radiomics revolution: AI and imaging in cancer care |
SL 07 (16:20-17:00) ![]() |
SL 08 (17:10-17:50) ![]() |
Date | Sep.5 (FRI) | ||||
---|---|---|---|---|---|
Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
08:40-10:10 | JS 07 JSMO/KSMO The new standard therapy in solid tumors : The combination of immunotherapies |
ES 05 Advance of technology - Artificial Intelligence in Oncology KOR |
SS 07 Novel opportunities to target cancer: Emerging strategies in molecular oncology |
JS 08 KSP/KSMO Biomarker for ADC |
SL 09 (8:40-9:20) ![]() |
SL 10 (9:30-10:10) ![]() |
|||||
10:10-10:30 | Break (20 min.) | ||||
10:30-11:10 | PL 03 Advances in chemotherapy for gastric cancer- Future perspectives |
||||
11:10-11:30 | Break (20 min.) | ||||
11:30-12:10 | LS 06![]() |
LS 07![]() |
LS 08![]() |
LS 09![]() |
LS 10![]() |
12:10-12:20 | Break (10 min.) | ||||
12:20-13:50 | JS 09 ASCO/KSMO |
OP 02 12:20-13:20 |
MDCD Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics KOR |
SS 08 Combinatory strategy to enhance immune checkpoint response |
SL 11 (12:20-13:00) ![]() |
SL 12 (13:10-13:50) ![]() |
|||||
13:50-14:00 | Break (10 min.) | ||||
14:00-14:40 | PL 04 Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer. |
||||
14:40-14:50 | Break (10 min.) | ||||
14:50-16:20 | JS 10 ESMO/KSMO How to streamline initiatives for optimising oncology practice |
SS 09 Real-world challenges in GI oncology: Navigating complex treatment decisions |
SS 10 Revealing immune response and resistance through spatial profiling of NSCLC microenvironment |
SL 13 (14:50-15:30) ![]() |
|
SL 14 (15:40-16:20) ![]() |
|||||
16:20-16:40 | Closing Ceremony | ||||